Portfolio of Coronavirus Stocks

The following table includes 22 coronavirus treatment and vaccine stocks.

22 Coronavirus Stocks



Recent Prices

Abbott LaboratoriesABT
Aethlon MedicalAEMD
AIM ImmunoTechAIM
Alpha Pro TechAPT
BioCryst PharmaceuticalsBCRX
Cleveland BioLabsCBLI
Emergent BioSolutionsEBS
Gilead SciencesGILD
InflaRx N.V.IFRX
Inovio PharmaceuticalsINO
Lakeland IndustriesLAKE
Mesoblast LimitedMESO
Ocean Bio-ChemOBCI
Regeneron PharmaceuticalsREGN
Roche HoldingRHHBY
Tonix PharmaceuticalsTNXP
Vir BiotechnologyVIR
Price charts from Alpha Vantage as of most recent close.

Portfolio Values

To inspect the performance of the Coronavirus Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 15 stocks included in the portfolio computations are: ABT, AIM, APT, BCRX, CBLI, EBS, GILD, INO, LAKE, NNVC, NVAX, OBCI, REGN, RHHBY and TNXP. The current value of the portfolio assumes that $666.67 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 7 stocks excluded from the portfolio computations because of insufficient price data are: AEMD, CODX, IFRX, MESO, MRNA, VXRT and VIR.

The current value of a $10,000 investment is $18,581. The percent return is 85.81%. The annualized return is 13.19%.

See Portfolio of Coronavirus Treatment and Vaccine Stocks.

See Portfolio of Coronavirus Vaccine Stocks.

See Portfolio of Coronavirus Virus Lockdown Stocks.

Related Portfolios

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Telemedicine Stocks

Portfolio of Vaccine Stocks